Indian pharma ramps up global alignment, enforces strict ICH & WHO standards: Nandita Vijayasimha, Bengaluru Friday, December 5, 2025, 08:00 Hrs [IST] Indian pharma is acceleratin ...
In September, the WHO added GLP-1 therapies to its Essential Medicines List for managing Type 2 diabetes in high-risk groups.
The WHO predicts that fewer than 10% of eligible patients will have access to GLP-1RAs by 2030.
India’s Department of Pharmaceuticals (DOD) released draft guidelines to boost research and development in its pharmaceutical and medical device industries. The document touched on the reasons for a ...
Oncologists who receive payments from industry may be more likely to prescribe non-recommended and low-value treatments. That is the assertion of a paper published in The BMJ that analyzed data on ...
Piramal Pharma Solutions, a global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd.